Dr Reddy’s Growth Strategy Sets Sights On Six Spaces

 
• By Dave Wallace

Dr Reddy’s chief operating officer Erez Israeli says six key areas – the US, China, Russia, India, APIs and hospital drugs – underpin the Indian company’s growth ambitions, with small-molecule generics remaining the firm’s “bread and butter”.

BreadAndButter
Dr Reddy’s Says It Will Spread Its Focus Across Six Key Areas, But Generics Will Remain Its “Bread And Butter” • Source: Shutterstock

More from Generics

More from Products